Chinoxalin

Quinoxaline

HCID 7045CAS 91-19-0

Grundinformationen

Standard-SMILES
c1ccc2nccnc2c1
InChIKey
XSCHRSMBECNVNS-UHFFFAOYSA-N
Summenformel
C8H6N2
Durchschnittliche Molmasse
130,15 g/mol
Monoisotopische Masse
130,05309819

Überblick

Quinoxaline is a naphthyridine in which the nitrogens are at positions 1 and 4. It is a mancude organic heterobicyclic parent, a naphthyridine and an ortho-fused heteroarene.

Namen und Bezeichner

Bevorzugter Name
Quinoxaline
IUPAC
quinoxaline
Lokaler Name
Chinoxalin
Englischer Name
Quinoxaline
Summenformel
C8H6N2
Molmasse
130.15

Namen und Synonyme

QUINOXALINE91-19-01,4-BenzodiazineBenzoparadiazineBenzopyrazinePhenopiazinePhenpiazineQuinazine1,4-DiazanaphthaleneBenzo[a]pyrazine1,4-NaphthyridineUSAF EK-7094
Weitere Namen anzeigen
QuinoxaLusafek-7094
ChinoxalinBenzo(a)pyrazineCCRIS 2947DTXSID6049432UNII-QM4AR6M6T8QM4AR6M6T8CHEBI:36616QUINOXALINE [MI]

Datenbank-Bezeichner

CAS
91-19-0
PubChem CID
7045
DTXSID
DTXSID6049432
ChEMBL
CHEMBL39444
ChEBI
CHEBI:36616
UNII
QM4AR6M6T8
EC Number
202-047-4
Nikkaji
J4.336B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,3
Polarare Oberfläche (TPSA)
25,8 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
0
Schwere Atome
10

Experimentelle und physikochemische Eigenschaften

SpringerMaterials Properties15N nuclear magnetic resonance spectrum
LogP1.35
Ionization Efficiency · 6 Einträge

Positive

2.11

2.7

Agilent XCT

Electrospray ionization

formic acid (5.3nM)

Physikochemische Eigenschaften

Schmelzpunkt
29 · 29-32 °C (lit.)
Siedepunkt
220 · 220-223 °C (lit.)
Dichte
1.124 g/mL · 1.124 g/mL at 25 °C (lit.)
Brechungsindex
48 · nD48 1.6231
Flammpunkt
209 °F · 209 °F
storage temp.
2 · 2-8°C

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 2 Einträge

Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)

Quinoxaline: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Sicherheitsdaten

wgk
3
tsca
TSCA listed
hs_code
29339990
RTECS-Nr.
VD1225000
risk_code
36/37/38-36/38
hazard_code
Xi

Chemie und Industrie

Verwendung und Herstellung

General Manufacturing InformationQuinoxaline: ACTIVE

Anwendungen

VerwendenQuinoxaline is a reagent used in the synthesis of quinoxaline diimides as small molecule non-fullerene acceptors for organic solar cells.

Anbieter50 Anbieter

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
北京福源坊科技有限公司010-57903446 15869909019 · [email protected]
湖北万得化工有限公司15377098680 15377098680 · [email protected]
盐城通铭生物科技有限公司15195160625 · [email protected]
武汉欣扬瑞和化学科技有限公司153-07155313 15307155313 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: A naphthyridine in which the nitrogens are at positions 1 and 4.

Zugehörige Reaktionen

36

Verknüpfte Notizen

Wird geladen…